Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...

CVS Caremark said in May that the move will save its employer clients 10 to 15% when compared to the previous year, the newspaper reported. Some employers won’t pay for either treatment because ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.